How is Polidocanol Intravenous Route dosed?
Polidocanol injection is available in both foam and solution dosage forms. The specific dosage and route of administration depend on the individual patient's needs and the condition being treated. The dosage forms are typically administered through a needle placed into a vein in a hospital setting by a nurse or other trained health professional.
For treatment of small varicose veins and incompetent great saphenous veins, accessory saphenous veins, and visible varicose veins above and below the knees, the recommended adult dose is 1.5% to 3% of the total volume of the vein being treated. The treatment session usually lasts about 15 to 30 minutes.
Please note that the dosage and administration are determined by a doctor and may vary based on factors such as age, medical history, and other medications being taken. Always follow your doctor's instructions and the informational leaflet provided with the medication for the most accurate and up-to-date information regarding dosing.
What is the dosage form of Polidocanol Intravenous Route?
The dosage forms of Polidocanol Intravenous Route are Foam and Solution.
How is Polidocanol Intravenous Route administered?
Polidocanol Intravenous Route is administered by a healthcare professional in a hospital setting through a needle placed into one of the patient's veins.
What are common precautions when taking Polidocanol Intravenous Route?
When taking Polidocanol Intravenous Route, common precautions to consider include:
- Allergies: Inform your healthcare professional if you have had any unusual or allergic reactions to this medicine or any other medicines. Also, let your doctor know if you have other types of allergies, such as to foods, dyes, preservatives, or animals.
- Blood clots or blood clotting disorders: This medicine should not be used in patients with blood clots or blood clotting disorders, acute.
- Blood clotting problems: Inform your doctor if you have a history of blood clotting problems, such as deep vein thrombosis or pulmonary embolism.
- Major surgery or prolonged immobilization: Polidocanol Intravenous Route may increase the risk for blood clotting problems in patients who have undergone recent major surgery or prolonged immobilization within the past 3 months.
- Blood vessel disease: Patients with blood vessel disease, such as peripheral arteriosclerosis or thromboangiitis obliterans, may have an increased risk for tissue ischemia (reduced blood flow) when using Polidocanol.
- Pediatric use: Appropriate studies have not been performed on the relationship of age to the effects of Polidocanol injection in the pediatric population. Safety and efficacy have not been established.
Always follow your doctor's instructions and seek medical advice if you experience any side effects or concerns while using Polidocanol Intravenous Route.